Skip to main content
xMedica

Search

29 studies match these filters. Showing 1–25 of 29 studies

Search results
Registration numberStudyStatusPhaseEnrolmentSites / countriesStart yearLast updatedActions
NCT07209397Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

The goal of this clinical trial is to learn if a vaginal radiofrequency (RF) device called MORPHEUSV works to treat overactive bladder (OAB) in women. Researchers also want to learn how safe the device is for this indication. This study will include women ages 22 to 80 who have had OAB symptoms for…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 9 sites in total · contact listed

RecruitingNot applicable202target9 / 12025Jan 30, 2026
NCT05685433A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed

RecruitingNot applicable200target22 / 12023Oct 19, 2026
NCT07220083A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by ch…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 309 sites in total · contact listed

RecruitingPhase 3286target309 / 372026Nov 13, 2026
NCT06942949Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, wit…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 20 sites in total · contact listed

RecruitingNot applicable101target20 / 12025Jun 16, 2026
NCT07155005Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study

The goal of this clinical trial is to evaluate the effectiveness and safety of Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System versus other commonly used renal-stone interventions.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 10 sites in total · contact listed

Recruiting1,000target10 / 12026Nov 2, 2026
NCT07624305A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

The purpose of this study is to evaluate the efficacy, safety and tolerability of balcinrenone in fixed combination with dapagliflozin, compared with dapagliflozin, in patients with CKD Stage 3b and 4 (eGFR ≥ 15 to \< 45 mL/min/1.73 m2) administered orally once daily in addition to SoC. This is a p…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 478 sites in total

RecruitingPhase 32,800target478 / 272026Sep 24, 2026
NCT06190717Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total · contact listed

RecruitingNot applicable304target23 / 12024Oct 28, 2026
NCT06742723A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and cardiovascular mortality in participants with chronic kidney disease and high blood pressure

✓ Contact✗ Claimed

Nearest site: Hutchinson, Kansas, United States — 36 km away · 771 sites in total

RecruitingPhase 35,000target771 / 422025Nov 6, 2026
NCT06567743Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Risk Non-Muscle-Invasive Bladder Cancer.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 80 sites in total · contact listed

RecruitingPhase 2325target80 / 22024Sep 3, 2026
NCT06510374Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC)

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 119 sites in total

RecruitingPhase 3454target119 / 102024Nov 12, 2026
NCT05485961Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1: Phase 2b is a dose-finding study for CSL300 vs placebo. Part 2: Phase 3 aims to assess the efficacy of CSL300 vs placebo on cardiovascular (CV) out…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 566 sites in total · contact listed

RecruitingPhase 2 / Phase 33,110target566 / 352024Sep 21, 2026
NCT06319820A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 193 sites in total

RecruitingPhase 3641target193 / 202024Nov 3, 2026
NCT07206056An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate cancer (mCRPC).

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 35 sites in total · contact listed

RecruitingPhase 1 / Phase 2188target35 / 142025Oct 9, 2026
NCT06533644A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

The primary purpose of this study is to evaluate the safety, tolerability, and efficacy of SYNC-T Therapy SV-102 and to identify the maximum tolerated dose (MTD) and/or selected dose for phase 2b study.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total

RecruitingPhase 291target23 / 12025Jun 23, 2026
NCT06056830Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 34 sites in total · contact listed

RecruitingPhase 3383target34 / 32023Sep 11, 2026
NCT07225946A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

The purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of treatment until disease worsens as determined by scans or death due to any cause) when compared to treatment with docetaxe…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 165 sites in total

RecruitingPhase 3800target165 / 172025Nov 3, 2026
NCT05946213Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a pa…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 436 sites in total

RecruitingPhase 31,500target436 / 52023Oct 23, 2026
NCT03866382Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blo…

✓ Contact✗ Claimed

Nearest site: Kingman, Kansas, United States — 28 km away · 582 sites in total

RecruitingPhase 2314target582 / 22019Nov 18, 2026
NCT04729114A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with advanced prostate cancer. It is given by an injection into the muscle. Men with advanced prostate cancer can take part in this study. Their canc…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 25 sites in total

RecruitingPhase 1174target25 / 22021Feb 4, 2026
NCT06545955A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3 months. In this trial, the safety and efficacy of intravesical instillation of nadofaragene firaden…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 81 sites in total

RecruitingPhase 3250target81 / 82024Nov 12, 2026
NCT07097142Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

This phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with standard of care chemotherapy, with cisplatin, gemcitabine or mitomycin and 5-fluorouracil for the treatment of patients…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 259 sites in total · contact listed

RecruitingPhase 3486target259 / 22025Oct 23, 2026
NCT07190300TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

The purpose of this study is to evaluate the safety, tolerability, and efficacy of two different treatment combinations of tulmimetostat in participants with de novo or recurrent metastatic hormone-sensitive prostate cancer (mHSPC). Phase I aims to determine the recommended dose(s) for expansion (RD…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 31 sites in total · contact listed

RecruitingPhase 1 / Phase 2181target31 / 142026Nov 13, 2026
NCT05677100Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejec…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 50 sites in total

RecruitingNot applicable320target50 / 22023Aug 25, 2026
NCT02402244Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 279 sites in total · contact listed

Recruiting75,000target279 / 62015Nov 19, 2026
NCT05334069Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early…

✓ Contact✗ Claimed

Nearest site: Wichita, Kansas, United States — 43 km away · 751 sites in total · contact listed

Recruiting2,900target751 / 12022Nov 4, 2026

Filters

Clear all filters